Archive for May, 2009
Duct Tape and Cryotherapy for Warts
The simple application of duct tape was more effective than cryotherapy in the treatment of common wart. Cutaneous warts are a common diagnosis in the pediatric population, and there are many treatments for the treatment of warts. Anecdotal reports on the effectiveness of tape occlusion therapy proposed. The warts that ultimately responded to tape therapy typically showed at least partial resolution after 2-3 weeks of treatment. Warts that have remained unchanged, were apparently the mark just three weeks to respond. Several potential benefits exist for the use of tape over cryotherapy. The band is more convenient for parents and patients to use, especially if they require several visits to the clinic compared to freeze the wart. In today’s hectic society, it is difficult for parents to keep track of appointments every two weeks for cryotherapy of warts their children. The lower success rate of cryotherapy arm is probably due in part on a more-than-optimal between treatments in some patients. It was a better drug adherence with prescribed treatment in the group of bands, mostly to ease of administration. Another benefit of tape occlusion therapy is that it is much less expensive than cryotherapy. Treatment can be done at home, with tape at low prices. Finally, tape occlusion therapy appears less threatening than a small child than freezing. The use of tape for the treatment of warts was generally well received by patients. Studies show that the band of effective treatment against warts, which can be used as an alternative treatment to cryotherapy. Position of the nipple may be effective therapy. Although both cryotherapy and tape occlusion therapy are well tolerated treatment is the profile of adverse tape occlusion therapy to be better. A variety of side effects with cryotherapy of warts have been reported, including pain perished during the procedure, erythema, vesicles, hemorrhagic dyspigmentation, recurrence of the wart, infection and nail dystrophy in treatment of warts. Although most patients tolerate the cryotherapy good children 6 years and less in the previous applications generally remembered as painful. The only negative effect in the group tape was the minimum amount of local irritation and redness. Practical considerations limit the use of duct tape therapy include difficulty for some patients on the meaning of the band, risk of exacerbation of disease in underlying skin conditions like eczema, and failure with cosmetics tape on his face. Consequently, although many treatments are available for wart removal, use of the tape as a safe and dangerous treatment for children is promising. Tape occlusion therapy proved more effective than cryotherapy vulgaris in the treatment of warts, and it makes fewer side effects. Medicinal plants provide profound results in a large number of complaints to heal, recent scientific studies prove this fact. Nature provides a remedy against warts, and various remedies for all sorts of evils. The beauty of these natural extracts is that they not only get incredible results to eradicate specific diseases, but do so without adverse effects. Warts occur on the body, face, feet, hands or genitals can be successfully removed with AntiWarts-Rx. This product is made from purely organic products antiviral plant material and concentrated with natural monoterpene ketones, the huge anti-viral activity against warts virus, HPV, showed how, in the published scientific studies. As some go their whole lives without warts, while others appear to be vulnerable to infection, it is generally regarded as an accident of warts associated with lower immunity against HPV. The result is a powerful ImmunoDrops warts organic food nature Pharma developed exclusively for the fight against HPV and to strengthen immune parameters in people with warts. A cure warts cons of the plant extract compounds are the molecules of life itself, in perfect harmony with the biochemical system of man. The antiviral properties of these treatments are not in dispute, the basic common sense should be considered when using a treatment, either natural or synthetic.
Dental Health Affects Your Whole Body Wellbeing
Maintaining dental health is one of the most important aspects of our daily routine. Not only is our attention to our standards of oral hygiene to prevent diseases of the oral cavity necessarily, but it can lead to many other physical ailments. Some of them can be remarkably dangerous. It is an activity that is not taken lightly. Plaque and it is larger and more toxic cousin tartar, infection (two teeth and gums), gingivitis and oral candidiasis are probably guilty, if you have a problem in your mouth. While many dental health problems can be prevented by regular brushing and flossing may require some more specific treatment of your dentist. Dental health is not just around the mouth While maximizing the health of the mouth, teeth and gums are very important in itself, the dental health can not be distinguished from general health. Oral disease can be indicative of a number of other diseases. In fact, with the condition of our mouth as a symptom can often tell if it is a serious underlying disease. It is always important to keep your mouth healthy and changes that affect you, your doctor or dentist. Remember that if you can do a lot of personal attention to dental hygiene, which also help at hand. You have a certain number of dentists who support helping the health of your teeth. You will be notified to help you improve your oral hygiene and, of course, deal with issues arise when you visit with them immediately. The effect of plaque in dental health – and more Look at the plaque, which sticks to teeth. It is an unpleasant sticky layer of bacteria that quickly attaches to our teeth and gums (not to mention the language as well). Plate comes from consuming sugar food – especially sweets tights themselves. Thus, a diet with foods, less sugar focuses not only beneficial to your size and shape, it has a real advantage to the health of teeth, too. And remember that the health of your teeth for a great cause – is the health of your whole body. In fact, the growth plate in his big mouth and sticky enough to slow or stop the flow in blood vessels. And it is very important when it comes to heart disease, and not issues of stroke and to mention. The plate is almost public enemy number one when it comes to dental health and the implications for other health problems for us all. It is important to remember that dental health and general health are not treated separately.
To Compare the Role of Glibenclamide and Pioglitazone Drugs in Type 11 Non- Insulin Dependent Diabetes Mellitus Patients
To compare the role of drug glibenclamide and pioglitazone in type 11 non-insulin-dependent diabetic patients. Authors: Raj Kumar Chohan, Ghulam Rasool Mashori, Ghulam Rasool Bhurgri, Shamim-u-Rehman Mustafa DahriGhulam, anise-u-Rehman. Introduction: Diabetes is the Greek word for “siphon” What is the first member and means for much of the urine is made. TRM “sweet” comes from a word Laton “filled” Honey “and was used by, because the urine was sweet (Wheeler, 2004) ketaocidosis diabetes is a life-threatening condition that some of hospitalization and treatment data. Recognition of this condition is almost important as even small delays can have an impact on survival (Nattrass 2006). Hypoglycemia induced by insulin in episodes in diabetic patients. Probably the most important factor for the prescription of insulin-treated patients achieving the goals necessary to prevent complications of diabetes, glucose. The incidence of hypoglycemia reflects the current inadequancy Mathod of insulin delievery cause inappropriate insulin OT concentration high, especially after eating some food at night blindness, and even more important risk factor for heart disease and stroke (Heller, 2003). Diabetes type 1 diabetes MELLITUSTYPE (DID): Type I diabetes occurs in children of all ages, both sexes and all groups athenic. Type 1 diabetes usually occurs through mechanisms. It is most common metabolic condition in children and adolescents (Bui, 2004). Type1diabetes is the immunological destruction of pancreatic B cells characterized by insulin deficiency. This leads to a common biochemical endpoint of the risk of hyperglycemia and ketoacidosis, but clinical Presentaion varies depending on the speed and degree of failure of B cells (Lambert & Bingley. 2005). Diabetes mellitus type II (NIDDM) Type II diabetes is a complex metabolic disorder associated with dysfunction of these B cells and with various degrees of insulin resistance major pathogenic factors of insulin resistance leads to diabetes type 2 and decreased insulin secretion, resulting from changes caused by the liver, skeletal muscle and pancreatic beta cells (Charles & Clark, 1996). Diabetes mellitus gestational diabetes mellitus: women who develop glucose intolerance, in late pregnancy and women with previously diagnosed diabetes. SECONDARY diabetes mellitus: Diabetes is a disease caused by secondary pancreatic system endocrime, genetic disease, or exposure to chemical agents. Type I diabetes – formerly called diabetes mellitus insluin (DID), the destruction of pancreatic beta cells that produced marked inslulinType – I-diabetes, formerly known as diabetes mellitus (IDDM), known characterized by destruction of cells beta in the pancreas, insulin is produced. Type 1 diabetes occurs most frequently in children and young adults, but it may be, at any age. (Anderson et al 2007). Type-11 diabetes is not only uprward. A pancreas that produce insulin insufficient. muscle cells of the liver, too much glucose, does not easily take in glucose release. (McCarren, 2008) Many genetic factors are involved in the development of diabetes. Because of the new genetic method to identify all the researchers closed the door cadidate gene for both non-insulin diabetes (Bernhard, 1995) dependent and insulin dependent. Women who had gestational diabetes are more likely to develop type 11diabetes itself. Women with diabetes are more disadvantaged group Pergnant. You need more intensive prenatal care and close monitoring of blood glucose, blood pressure and weight. (Jawed2006) Overweight children the progression of childhood obesity in adulthood should be developed with early complications, including diabetes and associated cardiovascular disease IgpG2. diabetes is the most common clinical form of diabetes accountingforabout 1990% of all cases, it is currently the global epidemic. 11diabetes mellitus by the use of infectious endogenous insulin is due, it is often the result of obesity and physical inactivity (WHO, 2007). PREVALACES & IINCIDENCE: Diabetes mellitus increases with age, 200 of the prevalence of diabetes was estimated at 0. 19% Persons <20 years and 8 6% in men> 20 years. It is considered the geographic variation in incidence of type 1 and type-11 in both diabetes mellitus. Scavandinvian has the highest incidence of type 1 diabetes in Finland, e. g, the incidence of 35/100, 000 € per year in the Pacific, at a price much lower in Japan and China the incidence is 1 to 3 / 100, 00 per year of type 1 diabetes, Europe North and from the United States a couplet (8to17/100, 000 per year). The prevalence of diabetes mellitus type 11 is the highest in Iceland some Pacific, intermediate in countries like India and the United States, and relatively low in Russia and China. This variability is probably due to genetic resources, environmental factors and beharioral (Power, 2005). Diabetes mellitus is also prevalence between different ethnic groups in a given country, it is usually directly applicable ethnic groups have their prevalence with age and increased more than 5% of people aged over 65, diabetes mellitus (David Owerback 1988). The global prevalence of diabetes has increased over the last two decades. The prevalence of diabetes mellitus type11 is expected to type 11 diabetes more frequently in Hispanic Native American, African, American, and Asians, Pacific Islanders, for non-Hispanic whites, the incidence is approximately equal Women and men in all population groups. Diabetes Type 11 is becoming more common as people live longer, and the prevalence of diabetes increases with age also seen more often than ever among young people, in conjunction with the rise of obesity Children prevalenceof type11 diabetes are still many countries with estimates, but in cases of diabetes in 2000and 2030th rank among people with diabetes Country2000 countries (milloin) Country2030 diabtes people (in millions) India31. 7India79. 47China20. 8China42. 3USA17. 7USA30. 3Indonesia8. 4Indonesia21. 3Japan6. 8Pakistan13. 9Pakistan5. 2Brazil11. 3Russian federation4. 6Bangladesh11. 1Brazil4. 6Japan8. 9Italy4. 3Philippines7. 8Bangladesh3. 2Egypt6. 7 (Wareham and FOROUHI 2oo6) drug treatment of diabetes mellitus: the biguanides lower blood sugar, they increase glucose uptake and use in skeletal muscle by reducing insulin resistance and reduce hepatic production of glucose (gluconeogenesis). lower blood sugar, like a bar MEASUREMENT reduced low and very low lipoprotein MEASURE (LDL and VLDL) and metformin has a half-life of approximately three hours and is excreted unchanged in urine. clinical type 2 diabetes who are overweight and are used to failure of treatment with metformin alone food. Adverse effects are dose-related gastrointestinal e. g anorexia, diarrhea, nausea, lactic acidosis produced rare but potentially fatal toxic effects. (Dale, 2003). Improved insulin sensitivity by activating certain genes involved in lipid synthesis and metabolism of carbohydrates and Rosigilitazone Piogiltazone are currently authorized. Thiazolidinediones. Thiazolidinediones do not cause hypoglycemia when used alone, but they are usually taken in combination with sulfonylureas. In some studies incouraging, thaiazolidiniones have very positive effects on the heart, including reducing blood pressure and enhancement products and triglyceride levels Cholestrol, including increased levels of HDL, the good Cholestrol. You can also block a molecule called 11 Best CSH which can play an important role in the metabolic syndrome and diabetes type11. A study that rosiglitazone may even improve the function of beta cells sugessted and thus prevent the progression of diabetes. Anemia, weight gain, increased risk of body fluid can worson heart failure. Troglitazone was, after some reports of heart failure. Liver failure withdrawn death Abd. Current Grant Thiazoldinediones not seem the same effects on the liver, although there are few reports of liver damage. In patients with failure dietry choice of a sulfonylurea or insulin therapy is controversial and empric benefit of insulin therapy are education, improving the postmark diagnosis reported receiving treatment for short-term intense untreated diabetes type 2 (Scarlett et al, 1984) sulfonylurea Two other groups or generations for their efficacy, duration, drug interactions, side effects profiles. Sulfonylureas enhance insulin action in cells placed in culture and stimulate the synthesis of glucose transporters (Jacobs et al 1998). A sulphonylurea drug should normally be the insulin secretagogue of choice, NICE (National Institute for Clinical Excellence) recommends that the generic drug must be perscribed (Scsade and al1998). RESEARCH Design and Methods: This study was in the deprtment Pharmacololgy and Therapeutics, Basic Medical Sciences Institute Jinnah Postgraduate Medical Centre, Karachi, under the supervision conducted DRR kind od: GhulamRsool Mashori, associate professor and head of the Department of Pharmacology and therapeutic colloboration with the medical department and a filter Unit111 clinic, medical service, JPMC, Karachi. Seventy NIDDM (Type II) diabetic patients were initially in the study of the Clinic Filter Type III at the Medical Unit and diabetic clinic. Of the 60 diabetic patients have been throughout the remaining period of the study involved 10 patients were discontinued due to poor comlpiance or change in residential areas instead. All patients were divided into two main groups, groupies and group II patients were selected in this study after the inclusion and exclusion. Inclusion criteria: patients newly diagnosed Diabtes non-insulin dependent mellitus. Diagnsed diabetes patients in their homes, have no history of any drug. Having both sexes aged between 30-60 years. patients with non insulin Depedent were treated with pioglitazone. patients diagnosed with non Imsulin Depedent mellitus, drug glibenclamide. CRIRERIA EXCLUSION: Patients with high blood pressure. Patients with liver disease. Patients with heart disease. Pregnancy and breastfeeding women. Patients with renal insufficiency. Patients with severe complications. MATERIAL laces. Lancet Hlder (TM2 many abbots Easy Touch ASEE 03). Glucometer (Medisense) optilim One Touch (Abbott). Blood Sugar trpis nest (for vitro diagnostic (IVD Labortries Abbott Medisense UK Ltd, Abigngdon, Ox14ITR, MASD UK). stored at least 30?, (4 ° -30 ° C) and a maximum 40 ° C (39 ° -86 ° F). Weight Machine Model 1101 Lot no. TANTIATA 312th. DRUGSTab: Daonil 5 mg (Aventis Pharma) class of drugs: a sulphonylurea. Generic Name: glyburide. MFGLIC: No 000 007 FB-No. 000220MFG date: 12:00 06EXP days :7-10Lot NO: B230Tab: Pioz (Hilton Pharm) PvtLTd. Tab: Poizer 15mgDrug Category: Thaiazolinedione. Generic Name: pioglitazone hydrochloride. MFG LIC: 000 W Registration No. 136 dated :3-03270MFG 06EXP Date: 3-o9Lot No: 6287Tab: Poizer (Hilton Pharma) Pvt Ltd PARAMETERS: fasting glucose (FBS). random blood sugar (RBS). weight. Tags Keywords: diabetes, diabetes non-insulin and diabetes-insulin depedent, Daonil, poizer from the insulin. RESULTS: Table 1Weight observed and blood glucose at baseline and day 0cm group11 group1 group 1Group pioglitazone, n = 11 n = 33Weight63 27Glibenclamide. 2 7 + 37 + 15 25 ° 56 ° 62nd Sugar172 fast. 7 + 13. 32 42 +12 188th o5 · Random blood Sugar285. 11 + 15 + 17 18 532 284th ° 07 °, all values mean ± SEM. Imagine a weight and blood glucose levels observed are expressed in early (Day-O) in Table No. shpwing body weight (bw) and blood sugar (msg/dl0 levels, observed at baseline (day 0) in both groups group11 9group: 1 &) Groups: 1 Weight (Kg’s) mean + SEM) 63 37 ± 2 Fasting blood glucose 25 ± 7 13 32 172nd, 285th and random blood sugar 11 ± 15 32 Group: 11 Weight (KG’s0 (mean + SEM) 62 7 ± 1 56 to fasting (42 ± mg/dl0 2005 12th 188th, 284th random blood sugar of 18 ± 03 17th Figure 2: List of weight and glucose levels observed reference (day 0) in group 1 and group 11 Weight: 9 kg), their average values 63rd 37.62. 7, fasting (mg / dl) is located at 172nd 71 188 42 Random blood glucose (mg / dl) 285 284th 18th 11 & TABLE: All parameters in the observation 2Peroidic Group1Goup1 (pioglitazone) n = 27 P-day 90Weight63 0 days 45days 90days-45-0to45Day. 37 ± 2 2563. 63 ± 2 63 ± 2 2663rd 23> 0 05 (NS)>; 0th 05 (NS), fasting blood glucose sugar172. 7 165 13 ± 32. 04 ± 98 153 8. 37 ± 7 59> 0. 05 (NS) 0 05 (NS), random blood sugar285. 11 ± 15 32 279. 63 255 78 ± 13. 56 ± 12 65> 0 05 (NS)> 0 05 (NS) All values are mean ± SEM shown. (NS) not significant. Table: 2Showing regular observations of all parameters in group 1 (piogiltazone) (No. 27) the weight value P (day 0 to day 45)> 0 05 (NS). FPG> 0 05 (NS) of random blood glucose> 0 05 (NS) P. Day 90 weight values> 0 05 (N. S), FBS> 0 05 (N. S) 7RBS> 0th 05 (N. S) SIGNIFICANTFIGURE NO: 2 showing the regular monitoring of all parameters in group 1 in 45 days and 26.63 days day0 90th-average weight (kg) 63 37.63 .. 63 FBS ( mg / dL) 172 7165. 04 153. 37, RBS (mg / dl) 285 11 279 78. 255 56. TABLE NO3Peroidic monitoring of all parameters Group11 Group 11 (glibenclamide) N = 33P-Day value 45days 90days 45days 0 days -0-of-45 90Weight62. 7 ± 1 64 ± 5665th 1064th second 55 ± 1 92> 0 05 (NS) 0 05 (sugar188 blood NS0Fasting. 42 ± 12 05 168 45. 99 140 ± 10. 06 ± 5 68> , 0 05 (NS)> 0 05 (S) random blood sugar284. 03 220 18 ± 17. 12 170 13 ± 39. 94 ± 5 80 <0005 (MS) 0002 (ms0 (a) significant (MS) values are mean ± SEM significantAll moderate. No3 expressed table: See the regular monitoring of all parameters in the Goupe: 11 groups: 11 with drug (glibenclamide) None of the patients (n = 33). It P-value is the day 0 to day 45> weight 0th 05 (NS), FBS> 0 05 (N. S) RBS <0005 (MS) <0th 01 – day and day 45-90 weight> 0 05 (NS) FBS (0 05) RBS <0002 (Mr. S0 moderately important. Figure 3: Shwing regular observations in all parameters of the 62nd Group 11 Weight 7.65. 64.64. 55 FBS (mg / dl) 188 42 168. 45 2006 140e RBS (mg / dl) 284 18 December 220th, 170 94 (day 0 days 45-90). Talk: In Denmark, Al Beck Nielsenet, Skillman TG (1981) of published studies show that building glibenclamide increased number of receptors on monocytes of patients with diabetes mellitus type 11. Some patients were treated with diet and were in the second generation agents sulfonyureas Cobin. The number insulin receptor, patients measured before and after treatment. Intrvenous glucose test shows insulin secretion afterthe sustained impairent starting point for drug therapy. However, patients who were drug pioglitazone some results in the secretion of insulin were obtained in violation of drug therapy early in development. Clinical observations have suggested that the second generation sulfonylureas can effect through a potentiation of insulin-stimulating insulin-secreting primary other drugs released into the year. After studying and treating WilliamC Dukworth al (1972), AFTRS, review with sulfonylureas is well documented that plasma insulin levels fell in response to oral glucose load. This place apparently has much glucose tolerance improved during treatment, the levels of this study clearly support that study. The result of the above is correlated with the research group 11 Bonnie & Kimmel (completed in 2005) produced the same results FBS reduced basis, and at the end of the study with a total reduction of 44% the 23th, while the results showed at the end of the study were p-value peroid (p <0.001 ). Alvarsson Even Michael et al (2003) the same type of study and found, and the general trend of the change in 22 years. 11% FBS and 40% resulted in 88 rbs at the end of the study was p-value (p <0001). But a study conducted by (Stone & Brown (2003) more didnot our results within the parameters of FBS and observers, a reduction of 26 years. 22%. CONCLUSION: In light of the discussion is that it is obiovus study, glibenclamide was more effective, consistent and safer than pioglitzone in a short time. Diabetes mellitus is a chronic disease to extend for a lifetime . poor communities can afford to go to the marketing of drugs to Pakistan for diabetic patients and easily buy purchase costs, in fact, most people do without perscription pharmacy RD because pharmacists to know and patients both on the disease. As dispirin as an analgesic, it is a drug known anti-diabetics in our country compared to other diabetes drugs. refernce: Anderson J, Kendall Perryman. S et al, “Diet and Diabetes” Diabetes 2006.16 (3) :17-19-Bui H type 1 diabetes in children medicine therapyin 2006.3 diabetes Diabetes Care Diabetes 0.1-11 3Bernhard 1995.19 (100:12-17-MC-Clark oral pharmacological type11 diabetes and clinical use of the existing use of the agent are currently available diabetes 1998.11 (4) :211-221. Carren M. Types of diabetes mellitus Diabetes 2006 10 (3) 0.07-David Owerback NJ-population prevalence of diabetes Diabetes 1988.02 (6) :31-32Dale MM, diabetes mellitus pharmacology 20035th edition :287-391st Heller SR – hypoglycemia and diabetic ketoacidosis hypoglycemia 2006:34 -Medicine (03) :102-110. Untraveling Jawad F of Mystry Diabetes’Diabetes 2006, 15 (3) :13-15. Jacobs, D, insulin for diabetes in 1998, 6 (3) 1160126. Bingliy Lambert the basic facts in medicine 2006.34 (6) :3-7. Natters M-and hyperglycemia-Ketoacdosis Medicine 2006 34 (3) :104-106. AC Power Epidemiology of Diabetes ABC type11 diabetes Diabetes 2005 , 1 (1) 7 9Scarlet oral therapy in diabetes sulfonylurea 11, 1984, 16 (10), 3-9. Schade DS, et al A controlled study against placebo in patients in the glimepiride diabetes mellitus diabetes randomized to 19 998, 38 (7), 636-641. Warchman Forouhi-Epidimology diabetes and diabetes-basic facts Medicine 2006 34 (2), the discovery 57-Gd-60Wheeler Aaccident led to the Nobel Prize for Canadian students and researchers , 2005.01 -02. Report of the WHO-Diabetes Health-and-Defiition types of diabetes in 2007, from 1.1 to 4.
